(Q30437261)

English

Measuring quality of life in patients with pleural mesothelioma using a modified version of the Lung Cancer Symptom Scale (LCSS): psychometric properties of the LCSS-Meso

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Measuring quality of life in patients with pleural mesothelioma using a modified version of the Lung Cancer Symptom Scale (LCSS): psychometric properties of the LCSS-Meso (English)

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

quality of life

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Psychometric Property

1 reference

based on heuristic

inferred from title

author name string

Patricia J Hollen

1

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Richard J Gralla

2

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Astra M Liepa

3

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

James T Symanowski

4

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

James J Rusthoven

5

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

publication date

6 July 2005

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Supportive Care in Cancer

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

14

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

11-21

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Diffuse malignant mesothelioma. Prospective evaluation of 69 patients

1 reference

https://api.crossref.org/works/10.1007%2FS00520-005-0837-0

21 January 2018

Outcomes of cancer treatment for technology assessment and cancer treatment guidelines. American Society of Clinical Oncology

1 reference

https://pubmed.ncbi.nlm.nih.gov/15999264

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Diagnosing and dealing with multicollinearity

1 reference

https://pubmed.ncbi.nlm.nih.gov/15999264

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adapting the Lung Cancer Symptom Scale (LCSS) to mesothelioma: using the LCSS-Meso conceptual model for validation

1 reference

https://pubmed.ncbi.nlm.nih.gov/15999264

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Measurement of quality of life in patients with lung cancer in multicenter trials of new therapies. Psychometric assessment of the Lung Cancer Symptom Scale.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15999264

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Current approach to malignant mesothelioma of the pleura

1 reference

https://pubmed.ncbi.nlm.nih.gov/15999264

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Methodologic guidelines for reports of clinical trials

1 reference

https://pubmed.ncbi.nlm.nih.gov/15999264

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Malignant pleural mesothelioma: a disease unaffected by current therapeutic maneuvers

1 reference

https://pubmed.ncbi.nlm.nih.gov/15999264

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combination of raltitrexed and oxaliplatin is an active regimen in malignant mesothelioma: results of a phase II study

1 reference

https://pubmed.ncbi.nlm.nih.gov/15999264

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II trial of pegylated-liposomal doxorubicin (Doxil) in mesothelioma

1 reference

https://pubmed.ncbi.nlm.nih.gov/15999264

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Assessing tumor-related signs and symptoms to support cancer drug approval

1 reference

https://pubmed.ncbi.nlm.nih.gov/15999264

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A phase II EORTC study of temozolomide in patients with malignant pleural mesothelioma

1 reference

https://pubmed.ncbi.nlm.nih.gov/15999264

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II study of vinorelbine in patients with malignant pleural mesothelioma

1 reference

https://pubmed.ncbi.nlm.nih.gov/15999264

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A review of chemotherapy trials for malignant mesothelioma

1 reference

https://pubmed.ncbi.nlm.nih.gov/15999264

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Gemcitabine for malignant mesothelioma: A phase II trial by the Cancer and Leukemia Group B.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15999264

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Quality of life as a clinical trial endpoint: determining the appropriate interval for repeated assessments in patients with advanced lung cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/15999264

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Assessing quality of life during chemotherapy for pleural mesothelioma: feasibility, validity, and results of using the European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire and Lung Cancer Module

1 reference

https://pubmed.ncbi.nlm.nih.gov/15999264

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Quality of life during clinical trials: conceptual model for the Lung Cancer Symptom Scale (LCSS).

1 reference

https://pubmed.ncbi.nlm.nih.gov/15999264

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Quality of life assessment in individuals with lung cancer: testing the Lung Cancer Symptom Scale (LCSS).

1 reference

https://pubmed.ncbi.nlm.nih.gov/15999264

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Validity, reliability, and neither

1 reference

https://pubmed.ncbi.nlm.nih.gov/15999264

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Continuing increase in mesothelioma mortality in Britain.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15999264

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Diffuse malignant mesothelioma of the pleura in Ontario and Quebec: a retrospective study of 332 patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/15999264

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Current Therapy for Mesothelioma

1 reference

https://pubmed.ncbi.nlm.nih.gov/15999264

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Normative data and trends in quality of life from the Lung Cancer Symptom Scale (LCSS).

1 reference

https://pubmed.ncbi.nlm.nih.gov/15999264

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The emerging role of antifolates in the treatment of malignant pleural mesothelioma

1 reference

https://pubmed.ncbi.nlm.nih.gov/15999264

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chemotherapy in malignant pleural mesothelioma. A review.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15999264

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II Study of Pemetrexed With and Without Folic Acid and Vitamin B12 as Front-Line Therapy in Malignant Pleural Mesothelioma

1 reference

https://pubmed.ncbi.nlm.nih.gov/15999264

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Assessing clinical significance in measuring oncology patient quality of life: introduction to the symposium, content overview, and definition of terms

1 reference

https://pubmed.ncbi.nlm.nih.gov/15999264

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Advances in the treatment of malignant pleural mesothelioma

1 reference

https://pubmed.ncbi.nlm.nih.gov/15999264

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma

1 reference

https://pubmed.ncbi.nlm.nih.gov/15999264

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Gemcitabine combined with carboplatin in patients with malignant pleural mesothelioma: a multicentric phase II study

1 reference

https://pubmed.ncbi.nlm.nih.gov/15999264

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00520-005-0837-0

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

release_chhzghsfnrbatpv2d2l5ouhrqy

1 reference

https://api.fatcat.wiki/v0/release/chhzghsfnrbatpv2d2l5ouhrqy

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q30437261&oldid=2194853951"